Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,743 | -2,059 | -5,467 | -11,716 | -6,847 |
| Depreciation Amortization | 55 | 54 | 54 | 5 | N/A |
| Other Working Capital | 397 | 29 | -698 | 567 | 242 |
| Other Operating Activity | 2,077 | 616 | 903 | 507 | 812 |
| Operating Cash Flow | $-6,214 | $-1,360 | $-5,209 | $-10,637 | $-5,793 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,810 | 0 | 188 | 1,541 | 95 |
| Common Stock Repurchased | N/A | N/A | 617 | N/A | -2 |
| Other Financing Activity | 58,363 | 596 | 819 | 2,527 | 20,530 |
| Financing Cash Flow | $61,172 | $596 | $1,624 | $4,068 | $20,623 |
| Exchange Rate Effect | 224 | 9 | -34 | 203 | 177 |
| Beginning Cash Position | 4,089 | 4,959 | 8,622 | 15,470 | 633 |
| End Cash Position | 59,271 | 4,204 | 5,004 | 9,104 | 15,640 |
| Net Cash Flow | $55,182 | $-755 | $-3,619 | $-6,367 | $15,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,214 | -1,360 | -5,209 | -10,637 | -5,793 |
| Free Cash Flow | -6,214 | -1,360 | -5,209 | -10,637 | -5,793 |